Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04126733
Title Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Bayer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
Miami Cancer Institute at Baptist Health South Florida Miami Florida 33176 United States Details
Illinois Cancer Specialists Arlington Heights Illinois 60005 United States Details
Minnesota Oncology Hematology, PA Minneapolis Minnesota 55404 United States Details
Nebraska Cancer Specialists Papillion Nebraska 68046 United States Details
New York Oncology Hematology. P.C. Albany New York 12206 United States Details
Willamette Valley Cancer Institute and Research Center Eugene Oregon 97401 United States Details
Sarah Cannon Cancer Center Nashville Tennessee 37203 United States Details
Texas Oncology-Arlington North Arlington Texas 76012 United States Details
Baylor Charles A. Sammons Cancer Center at Dallas Dallas Texas 75246 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Texas Oncology-Sherman Sherman Texas 75090 United States Details
Virginia Oncology Associates Newport News Virginia 23606 United States Details
Northwest Cancer Specialists, PC Vancouver Washington 98684 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field